Literature DB >> 17430995

Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.

Yan Xie1, Dennis W Wolff, Ming-Fong Lin, Yaping Tu.   

Abstract

Acquisition of androgen independence by prostate cancer is the key problem of prostate cancer progression. Vasoactive intestinal peptide (VIP), a neuropeptide, may act as a survival factor for prostate cancer cells under androgen deprivation. However, the molecular mechanisms by which VIP promotes the androgen-independent growth of androgen-sensitive prostate cancer cells have not been addressed. We therefore investigated the biological effect and signal pathway of VIP in LNCaP cells, a prostate cancer cell line that requires androgens for growth. We showed that low nanomolar concentrations of VIP, acting through G(s)-protein-coupled VIP receptors, can induce LNCaP cell growth in the absence of androgen. Blockade of androgen-receptor (AR) in these cells by AR antagonist bicalutamide or by anti-AR small interfering RNA, inhibited the proliferative effect of VIP. In addition, VIP stimulated androgen-independent activation of AR with an EC(50) of 3.0 +/- 0.8 nM. We then investigated VIP-stimulated signaling events that may interact with the AR pathway in prostate cancer cells. VIP regulation of AR activation, mediated by VIP receptors, was protein kinase A (PKA)-dependent, and extracellular signal-regulated kinase 1/2 (ERK1/2) activation contributes to VIP-mediated AR activation. Furthermore, PKA-dependent Rap1 activation is required for both ERK1/2 activation and androgen-independent AR activation in LNCaP cells upon VIP stimulation. Finally, we showed that VIP-induced AR activation was also present in prostate cancer CWR22Rv1 and PC3 cells transfected with the wild-type AR. Altogether, we demonstrate that VIP acting through its G(s)-protein-coupled receptors can cause androgen-independent transactivation of AR through a PKA/Rap1/ERK1/2 pathway, thus promoting androgen-independent proliferation of androgen-sensitive prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17430995     DOI: 10.1124/mol.107.033894

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

1.  Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells.

Authors:  Chuu-Yun A Wong; Hada Wuriyanghan; Yan Xie; Ming-Fong Lin; Peter W Abel; Yaping Tu
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.

Authors:  Fang Liang; Junmin Yue; Junyong Wang; Lijuan Zhang; Rui Fan; Hao Zhang; Qingsong Zhang
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

3.  Phosphodiesterase 4D inhibitors limit prostate cancer growth potential.

Authors:  Ginny L Powers; Kimberly D P Hammer; Maribella Domenech; Katsiaryna Frantskevich; Rita L Malinowski; Wade Bushman; David J Beebe; Paul C Marker
Journal:  Mol Cancer Res       Date:  2014-08-22       Impact factor: 5.852

4.  Gbetagamma signaling promotes breast cancer cell migration and invasion.

Authors:  Joseph K Kirui; Yan Xie; Dennis W Wolff; Haihong Jiang; Peter W Abel; Yaping Tu
Journal:  J Pharmacol Exp Ther       Date:  2010-01-28       Impact factor: 4.030

5.  Involvement of PACAP/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells.

Authors:  Alessandro Castorina; Salvatore Giunta; Soraya Scuderi; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2012-03-28       Impact factor: 3.444

6.  Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer.

Authors:  Leah S Lyons; Shuyun Rao; Wayne Balkan; Joanne Faysal; Carol A Maiorino; Kerry L Burnstein
Journal:  Mol Endocrinol       Date:  2007-12-13

7.  RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.

Authors:  Monica Logan; Philip D Anderson; Shahrazad T Saab; Omar Hameed; Sarki A Abdulkadir
Journal:  Am J Pathol       Date:  2013-07-16       Impact factor: 4.307

8.  VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1.

Authors:  Haoshen Shi; Thomas W Carion; Youde Jiang; Jena J Steinle; Elizabeth A Berger
Journal:  Prostaglandins Other Lipid Mediat       Date:  2016-03-26       Impact factor: 3.072

9.  Activation of Rap1 promotes prostate cancer metastasis.

Authors:  Candice L Bailey; Patrick Kelly; Patrick J Casey
Journal:  Cancer Res       Date:  2009-05-26       Impact factor: 12.701

10.  Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor.

Authors:  Kuang-Hsiang Chuang; Saleh Altuwaijri; Gonghui Li; Jiann-Jyh Lai; Chin-Yi Chu; Kuo-Pao Lai; Hung-Yun Lin; Jong-Wei Hsu; Peter Keng; Ming-Chi Wu; Chawnshang Chang
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.